SG Americas Securities
TARO

SG Americas Securities’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

SG Americas Securities’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,013
Closed -$128K – 3425
2024
Q1 		$128K Sell
3,013
-1,660
-36% -$69.9K ﹤0.01% 2352
2023
Q4 		$195K Buy
4,673
+921
+25% +$34K ﹤0.01% 2194
2023
Q3 		$141K Buy
+3,752
New +$141K ﹤0.01% 2555
2018
Q1 		– Sell
-2,592
Closed -$271K – 3614
2017
Q4 		$271K Sell
2,592
-2,434
-48% -$267K ﹤0.01% 2253
2017
Q3 		$566K Sell
5,026
-2,683
-35% -$292K 0.01% 1742
2017
Q2 		$864K Sell
7,709
-208
-3% -$23.5K 0.01% 1510
2017
Q1 		$923K Buy
7,917
+12
+0.2% +$1.33K 0.01% 1428
2016
Q4 		$832K Sell
7,905
-5,393
-41% -$565K 0.01% 1411
2016
Q3 		$1.47M Buy
13,298
+5,358
+67% +$710K 0.02% 912
2016
Q2 		$1.16M Sell
7,940
-390
-5% -$55.3K 0.01% 1207
2016
Q1 		$1.19M Buy
8,330
+530
+7% +$75.3K 0.01% 1203
2015
Q4 		$1.21M Buy
+7,800
New +$1.14M 0.01% 1021

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $10.6B AUM 19.99% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

SG Americas Securities's TARO Position: Q2 2024 in Review

SG Americas Securities sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 3,013 shares — an estimated $128K sold.

SG Americas Securities first reported a position in TARO in Q4 2015 and held it in 12 quarters. The position peaked at $1.47M in Q3 2016. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • SG Americas Securities reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 3,013 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $128K.
  • SG Americas Securities first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 12 quarters.
  • SG Americas Securities's Taro Pharmaceutical Industries Ltd. position peaked at $1.47M in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.